ArticleTheranostics2019

Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer.

Sheng-Jia Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.